The deletion of CCR6 also resulted in reduced trafficking of dendritic cells to the tumor site, consistent with previous studies, which demonstrated a reduced overall migratory ability of dendritic cells in CCR6-null mice [44, 45]. Here, CCR6 is linked to neoplasm.